Immunohistochemical Expression of uPA, uPAR, and PAI-1 in Breast Carcinoma
Authors:
- Edwin DublinEDEdwin Dublin
- Andrew HanbyAHAndrew Hanby
- Neera K. PatelNPNeera K. Patel
- Diana BarnesDBDiana Barnes
- 1 October 2000
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 157 (4) , 1219-1227
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- The urokinase plasminogen activator system as a target for prognostic studies in breast cancerBreast Cancer Research and Treatment, 1998
- Overexpression of urokinase receptor in breast cancer cells results in increased tumor invasion, growth and metastasisInternational Journal of Cancer, 1996
- Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and α2-macroglobulin receptor in human breast carcinomasInternational Journal of Cancer, 1996
- Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: An immunohistochemical comparison of normal, benign, and malignant breast tissuesCancer, 1996
- Expression and localization of elements of the plasminogen activation system in benign breast disease and breast cancersJournal of Cellular Biochemistry, 1993
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomasNature, 1990
- Urokinase-type plasminogen activator (u-PA) antigen is a predictor of early relapse in breast cancerFibrinolysis, 1990
- Tumors: Wounds That Do Not HealNew England Journal of Medicine, 1986
- Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascadeCell, 1986